AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 8638341 — intervention group
Group type: EXPERIMENTAL
Intervention: Naproxen 500 mg twice daily for seven days postoperatively
Number of subjects: 50
Study 8638341 — intervention group
Group type: COMPARATOR
Intervention: Control group (no NSAID treatment)
Number of subjects: 50
Study 1676530 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam
Number of subjects: 16
Study 1676530 — intervention group
Group type: COMPARATOR
Intervention: Flumazenil
Number of subjects: 16
Study 6223651 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulized salbutamol solution
Number of subjects: 12
Study 6223651 — intervention group
Group type: COMPARATOR
Intervention: Nebulized ipratropium bromide
Number of subjects: 12
Study 28943191 — intervention group
Group type: EXPERIMENTAL
Intervention: Temporary bilateral uterine artery occlusion and myomectomy (Group A)
Number of subjects: 64
Study 28943191 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic myomectomy only (Group B)
Number of subjects: 64
Study 26624250 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity pulsed ultrasound (LIPUS) for 20 minutes per day for 4 weeks at an incident intensity of 30 mW/cm².
Number of subjects: 10
Study 26624250 — intervention group
Group type: COMPARATOR
Intervention: Sham transducer (control group).
Number of subjects: 10
Study 25057105 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 g/day of Arthrospira platensis (Asp)
Number of subjects: 73
Study 25057105 — intervention group
Group type: COMPARATOR
Intervention: Placebo of equal protein content and energy
Number of subjects: 73
Study 23083772 — intervention group
Group type: EXPERIMENTAL
Intervention: AMG 145 (doses of 7, 21, 70, 210, or 420 mg SC; 21 or 420 mg IV; 14 or 35 mg QW ×6; 140 or 280 mg Q2W ×3; 420 mg every 4 weeks ×2)
Number of subjects: 113
Study 23083772 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 113
Study 23083772 — intervention group
Group type: EXPERIMENTAL
Intervention: AMG 145 (140 mg Q2W ×3)
Number of subjects: 113
Study 20179322 — intervention group
Group type: EXPERIMENTAL
Intervention: C.E.R.A. administered via intravenous (IV) route once every 2 weeks (Q2W)
Number of subjects: 0
Study 20179322 — intervention group
Group type: EXPERIMENTAL
Intervention: C.E.R.A. administered via subcutaneous (SC) route once every 4 weeks (Q4W)
Number of subjects: 0
Study 20179322 — intervention group
Group type: EXPERIMENTAL
Intervention: C.E.R.A. administration (IV or SC)
Number of subjects: 0
Study 20179322 — intervention group
Group type: EXPERIMENTAL
Intervention: Dosing schedule, administration route, and study type
Number of subjects: 0
Study 18990320 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg of DHEA daily for 12 weeks
Number of subjects: 33
Study 18990320 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study 15931623 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous cyanocobalamin every 14 days
Number of subjects: 0
Study 15931623 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous cyanocobalamin every 7 days
Number of subjects: 0
Study 15931623 — intervention group
Group type: COMPARATOR
Intervention: Control group (1 mg intravenous cyanocobalamin every 28 days)
Number of subjects: 0
Study 12939214 — intervention group
Group type: EXPERIMENTAL
Intervention: Prothrombotic risk factors
Number of subjects: 149
Study 12939214 — intervention group
Group type: EXPERIMENTAL
Intervention: Underlying predisposing conditions
Number of subjects: 149
Study 12939214 — intervention group
Group type: EXPERIMENTAL
Intervention: Factor V, protein C, protein S, elevated Lp(a)
Number of subjects: 149
Study 12939214 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of a prothrombotic risk factor with an underlying condition
Number of subjects: 149
Study 12939214 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased Lp(a)
Number of subjects: 149
Study 12939214 — intervention group
Group type: EXPERIMENTAL
Intervention: Protein C deficiency
Number of subjects: 149
Study 10483818 — intervention group
Group type: EXPERIMENTAL
Intervention: ECOG scale
Number of subjects: 100
Study 10483818 — intervention group
Group type: EXPERIMENTAL
Intervention: KPS scale
Number of subjects: 100
Study 9179835 — intervention group
Group type: EXPERIMENTAL
Intervention: Decision support using the hand-held patient-oriented insulin regimen optimizer (POIRO)
Number of subjects: 6
Study 9179835 — intervention group
Group type: COMPARATOR
Intervention: No decision support (control)
Number of subjects: 6
Study 1684416 — intervention group
Group type: EXPERIMENTAL
Intervention: Formulas with marine oil (0.2% or 0.4%)
Number of subjects: 0
Study 1684416 — intervention group
Group type: COMPARATOR
Intervention: Control formulas (identical to commercially available formulas)
Number of subjects: 0
Study 1684416 — intervention group
Group type: EXPERIMENTAL
Intervention: Marine oil feeding
Number of subjects: 0
Study 7049878 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythromycin combined with bromhexine
Number of subjects: 22
Study 7049878 — intervention group
Group type: COMPARATOR
Intervention: Erythromycin alone (implied control)
Number of subjects: 22
Study 6367528 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid (AMCA) 1 g t.i.d. 24 h prior to and following intradermal injection of anti-IgE
Number of subjects: 10
Study 6367528 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 29511019 — intervention group
Group type: EXPERIMENTAL
Intervention: Extra virgin coconut oil
Number of subjects: 94
Study 29511019 — intervention group
Group type: EXPERIMENTAL
Intervention: Unsalted butter
Number of subjects: 94
Study 29511019 — intervention group
Group type: EXPERIMENTAL
Intervention: Extra virgin olive oil
Number of subjects: 94
Study 29952500 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrosurgery
Number of subjects: 80
Study 29952500 — intervention group
Group type: COMPARATOR
Intervention: Scalpel or Scissors
Number of subjects: 80
Study 24918567 — intervention group
Group type: EXPERIMENTAL
Intervention: Ingenol mebutate 0.015% gel
Number of subjects: 329
Study 24918567 — intervention group
Group type: COMPARATOR
Intervention: Vehicle gel
Number of subjects: 329
Study 23010094 — intervention group
Group type: EXPERIMENTAL
Intervention: 17 alpha-hydroxyprogesterone caproate (250 mg, weekly intramuscular)
Number of subjects: 657
Study 23010094 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 657
Study 21077560 — intervention group
Group type: EXPERIMENTAL
Intervention: Motorcycle lighting with daytime running lights (DRLs)
Number of subjects: 75
Study 21077560 — intervention group
Group type: EXPERIMENTAL
Intervention: Age of the driver of the other vehicle
Number of subjects: 75
Study 21077560 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 75
Study 18707726 — intervention group
Group type: EXPERIMENTAL
Intervention: Cranberry juice cocktail (3 times daily)
Number of subjects: 188
Study 18707726 — intervention group
Group type: EXPERIMENTAL
Intervention: Cranberry juice cocktail (breakfast) then placebo (lunch and dinner)
Number of subjects: 188
Study 18707726 — intervention group
Group type: COMPARATOR
Intervention: Placebo (3 times daily)
Number of subjects: 188
Study 18707726 — intervention group
Group type: EXPERIMENTAL
Intervention: Cranberry juice (multiple daily dosing)
Number of subjects: 188
Study 15918389 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (1 microg kg(‐1))
Number of subjects: 60
Study 15918389 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 60
Study 12692453 — intervention group
Group type: EXPERIMENTAL
Intervention: Breathing Bear
Number of subjects: 72
Study 12692453 — intervention group
Group type: COMPARATOR
Intervention: Non-Breathing Bear
Number of subjects: 72
Study 10573193 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomipramine at 0.5 to 1.0 mg/kg twice daily
Number of subjects: 49
Study 10573193 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomipramine at 1.0 to 2.0 mg/kg twice daily
Number of subjects: 49
Study 10573193 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study 10573193 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioural therapy
Number of subjects: 49
Study 8916636 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants whose depression symptoms decreased from baseline to the end of treatment
Number of subjects: 0
Study 8916636 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants whose depression symptoms increased from baseline to the end of treatment
Number of subjects: 0
Study 1985673 — intervention group
Group type: EXPERIMENTAL
Intervention: Teaching at hospital A
Number of subjects: 190
Study 1985673 — intervention group
Group type: COMPARATOR
Intervention: Teaching at hospitals B, C, and D
Number of subjects: 190
Study 6218577 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxalactam
Number of subjects: 97
Study 6218577 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard antimicrobial therapy)
Number of subjects: 97
Study 31806944 — intervention group
Group type: EXPERIMENTAL
Intervention: Radial extracorporeal shock wave therapy (rESWT) with 2000 pulses; 2.5 bars; 5 Hz, 7 mins, performed twice a week for five weeks (10 sessions) and stabilization training
Number of subjects: 40
Study 31806944 — intervention group
Group type: COMPARATOR
Intervention: Sham rESWT and stabilization training
Number of subjects: 40
Study 31806944 — intervention group
Group type: EXPERIMENTAL
Intervention: Radial extracorporeal shock wave therapy (rESWT) with stabilization training
Number of subjects: 40
Study 31806944 — intervention group
Group type: COMPARATOR
Intervention: Sham rESWT with stabilization training
Number of subjects: 40
Study 29262276 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic third ventriculostomy with choroid plexus cauterization (ETV‐CPC)
Number of subjects: 100
Study 29262276 — intervention group
Group type: COMPARATOR
Intervention: Ventriculoperitoneal shunting
Number of subjects: 100
Study 25929812 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Interview (CI)
Number of subjects: 125
Study 25929812 — intervention group
Group type: COMPARATOR
Intervention: Standard Interview (SI)
Number of subjects: 125
Study 23499523 — intervention group
Group type: EXPERIMENTAL
Intervention: Echocardiographically-guided pacing mode (Mode 2)
Number of subjects: 22
Study 23499523 — intervention group
Group type: COMPARATOR
Intervention: Factory pacing mode (Mode 1)
Number of subjects: 22
Study 23499523 — intervention group
Group type: EXPERIMENTAL
Intervention: Both modes (Mode 1 and Mode 2)
Number of subjects: 22
Study 21616171 — intervention group
Group type: EXPERIMENTAL
Intervention: Carer education intervention (two home-delivered education sessions based on academic detailing)
Number of subjects: 0
Study 21616171 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 0
Study 19632665 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 units of intramuscular oxytocin (group 1)
Number of subjects: 251
Study 19632665 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 microg oral misoprostol (group 2)
Number of subjects: 251
Study 19632665 — intervention group
Group type: COMPARATOR
Intervention: No additional medication (group 3)
Number of subjects: 251
Study 17020910 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose diazepam (15 mg)
Number of subjects: 12
Study 17020910 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose diazepam (5 mg)
Number of subjects: 12
Study 17020910 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 14763723 — intervention group
Group type: EXPERIMENTAL
Intervention: Early full weight bearing (Group 2)
Number of subjects: 51
Study 14763723 — intervention group
Group type: COMPARATOR
Intervention: Early partial weight bearing (Group 1)
Number of subjects: 51
Study 14763723 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 51
Study 11559268 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise (aerobic training, 3.4 times/week for 18 weeks)
Number of subjects: 14
Study 11559268 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise (resistance training, 2.5 times/week for 15 weeks)
Number of subjects: 14
Study 11559268 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 14
Study 11559268 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise groups
Number of subjects: 14
Study 9394987 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular injection of gold sodium thiomalate
Number of subjects: 20
Study 9394987 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 7946917 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluid and salt supplementation (FSS) during hypokinesia
Number of subjects: 30
Study 7946917 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypokinetic subjects (no FSS)
Number of subjects: 30
Study 7946917 — intervention group
Group type: COMPARATOR
Intervention: Control subjects (10,000 running steps/d)
Number of subjects: 30
Study 3368545 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose neuroleptics
Number of subjects: 0
Study 3368545 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose neuroleptics (excluding relapsed patients)
Number of subjects: 0
Study 3368545 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative family attitudes (measured at study entry)
Number of subjects: 0
Study 31124218 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS (2 mA, 20 min)
Number of subjects: 18
Study 31124218 — intervention group
Group type: COMPARATOR
Intervention: SHAM (placebo)
Number of subjects: 18
Study 28290958 — intervention group
Group type: EXPERIMENTAL
Intervention: Practical training
Number of subjects: 285
Study 28290958 — intervention group
Group type: COMPARATOR
Intervention: Instruction video
Number of subjects: 285
Study 28290958 — intervention group
Group type: COMPARATOR
Intervention: Theoretical lecture
Number of subjects: 285
Study 26211873 — intervention group
Group type: EXPERIMENTAL
Intervention: Repetitive transcranial magnetic stimulation (rTMS) to the right temporal pole (RTP)
Number of subjects: 20
Study 26211873 — intervention group
Group type: EXPERIMENTAL
Intervention: Repetitive transcranial magnetic stimulation (rTMS) to the left temporal pole (LTP)
Number of subjects: 20
Study 26211873 — intervention group
Group type: COMPARATOR
Intervention: Control group with rTMS delivered to the vertex
Number of subjects: 20
Study 22906162 — intervention group
Group type: EXPERIMENTAL
Intervention: Romiplostim 750 μg
Number of subjects: 29
Study 22906162 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study 21519749 — intervention group
Group type: EXPERIMENTAL
Intervention: Flaxseed powder (60 g/day, 10 g ALA)
Number of subjects: 16
Study 21519749 — intervention group
Group type: COMPARATOR
Intervention: Isocaloric roasted cassava powder (60 g/day, fat-free)
Number of subjects: 16
Study 18050063 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium tempi music
Number of subjects: 29
Study 18050063 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast tempi music
Number of subjects: 29
Study 18050063 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed tempi music
Number of subjects: 29
Study 18050063 — intervention group
Group type: COMPARATOR
Intervention: No-music control
Number of subjects: 29
Study 16005478 — intervention group
Group type: EXPERIMENTAL
Intervention: Individuals with WS rating of happy faces as approachable
Number of subjects: 0
Study 16005478 — intervention group
Group type: EXPERIMENTAL
Intervention: Individuals with WS rating of less approachable face stimuli
Number of subjects: 0
Study 16005478 — intervention group
Group type: COMPARATOR
Intervention: Controls rating of happy faces
Number of subjects: 0
Study 16005478 — intervention group
Group type: COMPARATOR
Intervention: Controls rating of less approachable face stimuli
Number of subjects: 0
Study 12929758 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure to a mental rotation task (adapted Cube Comparison test)
Number of subjects: 113
Study 12929758 — intervention group
Group type: EXPERIMENTAL
Intervention: Detailed instructions
Number of subjects: 113
Study 12929758 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 113
Study 10638870 — intervention group
Group type: EXPERIMENTAL
Intervention: Portable 3-D scanner
Number of subjects: 23
Study 10638870 — intervention group
Group type: COMPARATOR
Intervention: Multipurpose 2-D real-time scanner
Number of subjects: 23
Study 9113580 — intervention group
Group type: EXPERIMENTAL
Intervention: Temporal approach phacoemulsification
Number of subjects: 80
Study 9113580 — intervention group
Group type: COMPARATOR
Intervention: Superior approach phacoemulsification
Number of subjects: 80
Study 7691775 — intervention group
Group type: EXPERIMENTAL
Intervention: Grid laser treatment (low energy scatter photocoagulation applied to areas of presumed CNV and abnormal retinal pigment epithelium, sparing the fovea)
Number of subjects: 24
Study 7691775 — intervention group
Group type: COMPARATOR
Intervention: Natural course (control group)
Number of subjects: 24
Study 7691775 — intervention group
Group type: EXPERIMENTAL
Intervention: Grid laser treatment
Number of subjects: 24
Study 7691775 — intervention group
Group type: EXPERIMENTAL
Intervention: Grid laser treatment and Natural course (control group)
Number of subjects: 24
Study 3531036 — intervention group
Group type: EXPERIMENTAL
Intervention: Dipyridamole plus aspirin
Number of subjects: 407
Study 3531036 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 407
Study 30037621 — intervention group
Group type: EXPERIMENTAL
Intervention: Sound intervention
Number of subjects: 0
Study 30037621 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 27941937 — intervention group
Group type: EXPERIMENTAL
Intervention: Pegylated-interferon-alpha-2b monotherapy or combination therapy with adefovir dipivoxil
Number of subjects: 0
Study 27941937 — intervention group
Group type: COMPARATOR
Intervention: Pegylated-interferon-alpha-2b
Number of subjects: 0
Study 27941937 — intervention group
Group type: EXPERIMENTAL
Intervention: NKp30+ NK cells
Number of subjects: 0
Study 27941937 — intervention group
Group type: EXPERIMENTAL
Intervention: IL-15
Number of subjects: 0
Study 24323035 — intervention group
Group type: EXPERIMENTAL
Intervention: Sunitinib 37.5 mg/d continuously plus prednisone 5 mg twice daily
Number of subjects: 873
Study 24323035 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus prednisone 5 mg twice daily
Number of subjects: 873
Study 22112424 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief Intervention for Socially Anxious Drinkers (BISAD)
Number of subjects: 41
Study 22112424 — intervention group
Group type: COMPARATOR
Intervention: Alcohol psychoeducation
Number of subjects: 41
Study 20230604 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple P, level 3
Number of subjects: 0
Study 20230604 — intervention group
Group type: COMPARATOR
Intervention: Care as usual
Number of subjects: 0
Study 19001962 — intervention group
Group type: EXPERIMENTAL
Intervention: High FFP:PRBC ratio (≥1:1.5, n ≤ 102)
Number of subjects: 415
Study 19001962 — intervention group
Group type: COMPARATOR
Intervention: Low FFP:PRBC ratio (<1:1.5, n ≤ 313)
Number of subjects: 415
Study 19001962 — intervention group
Group type: EXPERIMENTAL
Intervention: High FFP:PRBC ratio (≥1:1.5)
Number of subjects: 415
Study 19001962 — intervention group
Group type: COMPARATOR
Intervention: Low FFP:PRBC ratio (<1:1.5)
Number of subjects: 415
Study 15545978 — intervention group
Group type: EXPERIMENTAL
Intervention: NRG1 haplotypes and markers
Number of subjects: 111
Study 15545978 — intervention group
Group type: EXPERIMENTAL
Intervention: NRG1 transcript expression in peripheral leukocytes
Number of subjects: 111
Study 15545978 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation of NRG1 variants
Number of subjects: 111
Study 12860491 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin (40-80 mg)
Number of subjects: 212
Study 12860491 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin (20-80 mg)
Number of subjects: 212
Study 10547243 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus GG (1 x 10(10) - 2 x 10(10) CFU per day)
Number of subjects: 202
Study 10547243 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 202
Study 10547243 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus GG
Number of subjects: 202
Study 8905602 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral oestradiol
Number of subjects: 83
Study 8905602 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 83
Study 7506866 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefotiam 4 g a day for 7 days (arm A)
Number of subjects: 150
Study 7506866 — intervention group
Group type: EXPERIMENTAL
Intervention: Tosufloxacin 300 mg a day for 7 days (arm B)
Number of subjects: 150
Study 2885368 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound detector (UD)
Number of subjects: 46
Study 2885368 — intervention group
Group type: COMPARATOR
Intervention: Clinical rating (CR) scale
Number of subjects: 46
Study 2885368 — intervention group
Group type: COMPARATOR
Intervention: Normal subjects (control)
Number of subjects: 46
Study 29040226 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxandrolone and propranolol (Oxprop)
Number of subjects: 42
Study 29040226 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study 27404645 — intervention group
Group type: EXPERIMENTAL
Intervention: Stage of change
Number of subjects: 3213
Study 27404645 — intervention group
Group type: EXPERIMENTAL
Intervention: Effort
Number of subjects: 3213
Study 27404645 — intervention group
Group type: EXPERIMENTAL
Intervention: Severity (sun severity)
Number of subjects: 3213
Study 27404645 — intervention group
Group type: EXPERIMENTAL
Intervention: Severity (smoking severity)
Number of subjects: 3213
Study 26243795 — intervention group
Group type: EXPERIMENTAL
Intervention: Statins
Number of subjects: 9140
Study 26243795 — intervention group
Group type: COMPARATOR
Intervention: Untreated patients (Control)
Number of subjects: 9140
Study 23579893 — intervention group
Group type: EXPERIMENTAL
Intervention: Xeno V
Number of subjects: 48
Study 23579893 — intervention group
Group type: EXPERIMENTAL
Intervention: Clearfil S(3) Bond
Number of subjects: 48
Study 23579893 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 48
Study 23579893 — intervention group
Group type: EXPERIMENTAL
Intervention: G-Bond
Number of subjects: 48
Study 20463100 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium (1200 mg daily) plus placebo
Number of subjects: 99